We describe a patient with chronic myeloid myeloid leukemia (CML) on tow-dose treatment with interferon (IFN) who developed systemic sarcoidosis, a rare IFN-related side effect, while in complete cytogenetic remission. We chose to continue IFN and to treat the sarcoidosis with prednisone. After eight months, the CML is still in complete cytogenetic remission and the sarcoidosis is almost completely resolved.
Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia / C., Fiorani; Sacchi, Stefano; G., Bonacorsi; Cosenza, Maria. - In: HAEMATOLOGICA. - ISSN 0390-6078. - STAMPA. - 85:9(2000), pp. 1006-1007.
Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia
SACCHI, Stefano;COSENZA, Maria
2000
Abstract
We describe a patient with chronic myeloid myeloid leukemia (CML) on tow-dose treatment with interferon (IFN) who developed systemic sarcoidosis, a rare IFN-related side effect, while in complete cytogenetic remission. We chose to continue IFN and to treat the sarcoidosis with prednisone. After eight months, the CML is still in complete cytogenetic remission and the sarcoidosis is almost completely resolved.
| File | Dimensione | Formato | |
|---|---|---|---|
|
1006.full.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
92.1 kB
Formato
Adobe PDF
|
92.1 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
